Search our Insights Archive
The Delphi Method: How to Strengthen your Value Proposition Through Collective Intelligence
When visiting a sensitive, emotive topic as a means to creating or refining a communications strategy, how can you optimize the true value of the voice of your customer? Join Purdie Pascoe’s expert presenters, Head of MedTech, Sabera Hyderally and Pharma Director, Hazel Haskayne, for this insightful live webinar on Wednesday 9th April to learn about the true value of the Delphi Method.
Storytelling in Market Research: Insights from the EPHMRA One-Day Meeting
Stephen Potts and Seb Newton recently attended the 2025 UK One-Day EPHMRA meeting in London. The focus of the event was ‘Storytelling in Market Research’ and how as market researchers, our mission is to ensure the insights we deliver tell a meaningful, powerful story to a diverse range of stakeholders. This summary delves into key themes and presentations from experts in the field.
Rare Diseases Day 2025
There are over 300 million people living with a rare disease across the globe, and they need help. Purdie Pascoe is dedicated to partnering with life science companies to make timely, informed decisions, and help improve the lives of those affected by rare diseases worldwide.
Spotlight on Precision Medicine and Diagnostics
Marianne Fillion provides insights about the Precision Medicine and Diagnostics market research function at Purdie Pascoe. She delves into technological advancements, the competitive oncology landscape and why market research is so important for development and implementation in this space.
Unlocking Competitive Edge: The Strategic Power of Diagnostic Market Research
Watch this webcast in which Director and Precision Medicine expert Marianne Fillion reveals how market research can unlock integral insights such as key customer trends, product adoption and patient leakage.
Tumor Agnostic testing – Awareness of biomarkers, Market landscape and Approaches
Tumor agnostic indications present specific challenges that must be addressed to achieve a successful launch and ensure wide access for all patients. To prepare for these complex product and indications launches, it is paramount for commercial teams to gain insights on tumor agnostic testing behaviors, including awareness, adoption, drivers and barriers.